Features typical of astrocytomas, such as copy-neutral loss of heterozygosity at 17p and the deletion of the cyclin-dependent kinase inhibitor 2A (CDKN2A) gene, were also detected in both cases. This evidence concerns the gene CDKN2A and astrocytoma (excluding glioblastoma).